A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
View ORCID ProfileAnthony R. Ives, View ORCID ProfileClaudio Bozzuto
doi: https://doi.org/10.1101/2021.03.17.21253793
Anthony R. Ives
1Department of Integrative Biology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Claudio Bozzuto
2Wildlife Analysis GmbH, Oetlisbergstrasse 38, 8053 Zurich, Switzerland.
Data Availability
All data used in this study are published and referenced in the main text.
Posted March 17, 2021.
A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
Anthony R. Ives, Claudio Bozzuto
medRxiv 2021.03.17.21253793; doi: https://doi.org/10.1101/2021.03.17.21253793
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)